Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M34.1Revenue $M6.2Net Margin (%)-179,395.3Z-Score-7.0
Enterprise Value $M-7.9EPS $0.2Operating Margin %-213,526.7F-Score4
P/E(ttm))0Cash Flow Per Share $-1.4Pre-tax Margin (%)-196,521.3Higher ROA y-yN
Price/Book4.710-y EBITDA Growth Rate %0Quick Ratio0.9Cash flow > EarningsY
Price/Sales05-y EBITDA Growth Rate %-13.5Current Ratio0.9Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-52.1Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-213.5Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M65.5ROI % (ttm)-76.6Gross Margin Increase y-yY

Gurus Latest Trades with AEZS

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
Current Price Change from Average Comment Current Shares
AEZSJean-Marie Eveillard 2010-03-31 Sold Out $4.8 - $5.58
$ 0.52-90%Sold Out0
AEZSJean-Marie Eveillard 2009-12-31 Reduce$4.74 - $7.5
$ 0.52-92%Reduce -91.09%124,518
AEZSJean-Marie Eveillard 2009-09-30 Buy 0.02%$5.34 - $16.98
$ 0.52-95%New holding, 1397897 sh.1,397,897
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

AEZS is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!

AEZS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Ernst, JrgenDirector 2014-11-12Buy3,100$0.61-13.11view
Ernst, JrgenDirector 2014-11-12Buy60,000$0.6-11.67view
Ernst, JrgenDirector 2014-11-12Buy39,400$0.62-14.52view
Ernst, JrgenDirector 2014-11-12Buy7,600$0.61-13.11view
Ernst, JrgenDirector 2014-11-12Buy14,900$0.61-13.11view
Egbert, CarolynDirector 2014-11-10Buy5,000$0.59-10.17view
Egbert, CarolynDirector 2014-11-10Buy9,000$0.59-10.17view
Egbert, CarolynDirector 2014-11-10Buy30,253$0.58-8.62view
Egbert, CarolynDirector 2014-11-10Buy9,144$0.57-7.02view
Egbert, CarolynDirector 2014-11-10Buy12,603$0.57-7.02view

Press Releases about AEZS :

    Quarterly/Annual Reports about AEZS:

      News about AEZS:

      Articles On GuruFocus.com
      Billionaires Hold Waning Biotechs 42% Off Oct 16 2013 
      Can Keryx Succeed Without Partnership? Apr 24 2012 
      Keryx Still Has High Potential from Zerenex Apr 12 2012 
      comment on AEZS Oct 26 2011 
      Opportunistic Coat-tailing Jan 05 2010 

      More From Other Websites
      Nasdaq stocks posting largest volume increases Jan 22 2015
      UPDATE - MONDAY DEADLINE: LEVI & KORSINSKY, LLP Notifies Investors Of Class Action Against Aeterna... Jan 09 2015
      Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action against... Jan 08 2015
      INVESTOR ALERT: Glancy Binkow & Goldberg LLP Announces an Expanded Class Period in the Shareholder... Jan 06 2015
      EQUITY UPDATE: Rosen Law Firm Expands Class Period in Aeterna Zentaris, Inc. Investor Class Action... Jan 06 2015
      INVESTOR ALERT: Investors of Aeterna Zentaris Inc. With Losses of $100,000 or More Are Encouraged to... Jan 06 2015
      January 6, 2015 Aeterna Zentaris to Present at Upcoming Biotech Showcase Conference in San Francisco Jan 06 2015
      Aeterna Zentaris to Present at Upcoming Biotech Showcase Conference in San Francisco Jan 06 2015

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      Free 7-day Trial